| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Salmeterol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pirbuterol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Terbutaline |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Orciprenaline (substance) |
Is a |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ritodrine (substance) |
Is a |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide+eformoterol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide+eformoterol fumarate 200/6mcg bth-act dry pdr inh (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide+eformoterol fumarate 100/6mcg bth-act dry pdr inh (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Selective beta-2 adrenoceptor stimulants adverse reaction |
Causative agent (attribute) |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Reproterol adverse reaction |
Causative agent (attribute) |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rimiterol adverse reaction |
Causative agent (attribute) |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tulobuterol adverse reaction |
Causative agent (attribute) |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Allergy to beta-2 adrenergic receptor agonist |
Causative agent (attribute) |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to reproterol |
Causative agent (attribute) |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rimiterol allergy |
Causative agent (attribute) |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to tulobuterol (finding) |
Causative agent (attribute) |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing beta-2 adrenergic receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Reproterol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rimiterol hydrobromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salmeterol+fluticasone propionate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tulobuterol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bambuterol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Reproterol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing rimiterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing tulobuterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bambuterol hydrochloride |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Eformoterol |
Is a |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fenoterol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bambuterol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Reproterol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rimiterol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tulobuterol (substance) |
Is a |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide+eformoterol fumarate dihydrate 400micrograms/12micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levosalbutamol |
Is a |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Formoterol |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clenbuterol |
Is a |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Arformoterol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to beta-2 adrenergic receptor agonist |
Causative agent (attribute) |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Vilanterol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Indacaterol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Procaterol |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olodaterol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hexoprenaline (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tretoquinol |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Orciprenaline adverse reaction |
Causative agent (attribute) |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Ritodrine adverse reaction (disorder) |
Causative agent (attribute) |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Fenoterol hydrobromide (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Terbutaline sulfate |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salmeterol xinafoate |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol sulfate |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pirbuterol acetate |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Indacaterol maleate (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nebivolol hydrochloride (substance) |
Is a |
False |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Arformoterol tartrate (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Vilanterol trifenatate (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tretoquinol hydrochloride |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Procaterol hydrochloride (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olodaterol hydrochloride |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Formoterol fumarate (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Formoterol fumarate dihydrate (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bitolterol mesilate |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bitolterol (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isoetharine |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isoetarine mesilate (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isoetarine hydrochloride (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Indacaterol acetate (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Formoterol fumarate anhydrous (substance) |
Is a |
True |
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]